EXAM 4 Diabetes Drugs Dr. Hess Flashcards
(41 cards)
What is the backbone of treating Prediabetes and T2DM?
-Medical nutrition therapy -> individualized meals (dietitian) -> weight loss
-Exercise
MOA of Metformin
Insulin Sensitizer (reducing Insulin resistance)
-reduces hepatic glucose production and glucose absorption in the gut
What is the most common side effect of Metformin?
Diarrhea
-it reduces glucose absorption in the gut -> glucose stays in the gut where bacteria comes in
What are ways to reduce the adverse effects of diarrhea when taking Metformin?
-take with food
-titrate weekly (increase by 500 mg)
-use the ER formulation
What is the maximum dose of Metformin?
2550 mg/day (850mg TID)
the maximum dose that is actually effective and seen in practice is 2000 mg
-titrate up until 2000 mg or control of blood glucose
-if blood glucose is controlled then don’t need to go to 2000 mg and potentially cause diarrhea (dose-depndent)
How much does Metformin lower A1c?
on average 1-2%
(reducing A1c by more than 1% is considered high efficacy)
What is the risk of Hypoglycemia of Metformin?
Low
-since it doesn’t stimulate insulin release but increases sensitivity
How does Metformin affect weight?
weight-neutral
Contraindications of Metformin
-Renal disease (eGFR < 30)
->excreted 100% in the kidney
-use of contrast dye - nephrotoxic (eGFR < 60)
-BBW: Lactic acidosis (don’t give if hx of Lactic acidosis)
-reduces Vitamin B12 absorption
A patient’s eGFR on Metformin has decreased to 35, what is the medical approach to it?
eGFR: 30-45
-if they were not on Metformin don’t start
-if they are on Metformin: consider a 50% dose reduction and close monitoring
if the eGFR is below 30: CONTRAINDICATED
if eGFR is over 45: it is OK to start or continue
MOA of SGLT2i
blocking glucose reabsorption in the kidney
-> excreted via urine
Efficacy of SGLT2i
0.5 - 1% (moderate)
What are the other protective effects of SGLT2i?
-Cardiovascular protective (heart failure)
-Renal protective (CKD)
Hypoglycemia risk for SGT2i
Low
Adverse effects of SGLT2i
Mycotic infections, UTI
-Polyuria
-dehydration (mild diuretic)
-Hypotension
-Weight loss !!!
-Euglycemic diabetic ketoacidosis (rare)
Why may patients on SGLT2i develop Euglycemic diabetic ketoacidosis?
the blood glucose is normal (normal-high) but they are acidic
they pee out the sugar which lowers the blood glucose
When are SGLT2i contraindicated?
severe renal dysfunction (eGFR < 20)
Which SGLT2i is indicated for T2DM with ASCVD, HF, and CKD?
Jardiance (Empagliflozin)
What is the indication of Farxiga (dapagliflozin)?
T2DM
HF
CKD
What is the indication of Invokana (Canagliflozin)?
T2DM
T2DM with ASCVD
T2DM with CKD
had a BBW for imputations, but it was removed
-not often used in practice
What is the risk of hypoglycemia for SGLT2i when combined with other antidiabetics?
-SGLT2i has a low risk of hypoglycemia
-SU has a higher risk of hypoglycemia -> combined higher risk for hypoglycemia
reduce the dose of SU to reduce the risk of hypoglycemia
Which SGLT2is have shown renal benefits?
Farxiga (dapagliflozin)
Invokana (canagliflozin)
Which of the SGLT2i have HF benefits?
Farxiga (dapagliflozin)
Jardiance (empagliflozin)
Which of the SGLT2i have CVD benefits?
Jardiance (empagliflozin)
Invokana (canagliflozin)